Receiving a mosaic embryo result from preimplantation genetic testing can feel like receiving bad news, but the picture is more nuanced than a simple positive or negative. Mosaicism is not the same as full aneuploidy, and for some patients, transferring a mosaic embryo is a legitimate clinical option that has resulted in healthy pregnancies and births.
Understanding what mosaicism actually means, how it differs from aneuploid results, and what the evidence shows about transfer outcomes helps patients make more informed decisions about embryos that fall into this gray zone.
At Hanabusa IVF, the team helps patients understand the clinical significance of every PGT-A result, including mosaic findings, so that transfer decisions are grounded in evidence rather than assumption.
What Is a Mosaic Embryo?
A mosaic embryo is one in which the cells are not all genetically identical. Specifically, some cells carry the correct number of chromosomes (46, euploid) while others do not (aneuploid). Mosaicism occurs when chromosomal errors arise after fertilization, during the early cell divisions of embryo development, rather than being present in the original egg or sperm.
This is distinct from a fully aneuploid embryo, where all or nearly all cells carry chromosomal abnormalities. In a mosaic embryo, the proportion of abnormal cells varies, and that proportion matters clinically.
Why Does Mosaicism Happen?
After fertilization, the early embryo undergoes rapid cell divisions. During these divisions, errors in chromosome segregation can occur in individual cells, creating daughter cells with incorrect chromosome numbers. If this error happens in one of the early cell divisions, a proportion of the resulting embryo's cells will carry the error. The higher up in the division sequence the error occurs, the more cells will be affected.
Mosaicism is not preventable, and it is not caused by anything the patient or partner did. It is a natural biological phenomenon that occurs in a proportion of embryos across all patients, though the rate may differ by age and other factors.
What the PGT-A Report Shows, and What It Does Not Show
PGT-A biopsy samples a small number of cells from the outer layer (trophectoderm) of the blastocyst, the cells that will form the placenta. The genetic result from this biopsy represents those cells, but not necessarily every cell in the embryo. A mosaic result means that the trophectoderm biopsy detected a mix of chromosomally normal and abnormal cells.
This has an important implication: a mosaic result is a sample-based finding. It reflects the chromosomal composition of the biopsied cells, not a definitive map of every cell in the embryo. Some embryos classified as mosaic by PGT-A have resulted in healthy, chromosomally normal births, which suggests that the inner cell mass (ICM), which becomes the fetus, may have had a different chromosomal composition than the trophectoderm that was sampled.
"Mosaicism is genuinely complex. We used to treat mosaic embryos essentially the same as aneuploid ones. The evidence has evolved, and now we understand that the level of mosaicism, the specific chromosomes involved, and the patient's overall embryo situation all matter when making a recommendation. It is not a one-size-fits-all answer."
— Dr. Lyndon Chang, Medical Director at Hanabusa IVF
Low-Level Mosaicism vs. High-Level Mosaicism
Not all mosaic results are equivalent. PGT-A laboratories typically classify mosaicism by the proportion of abnormal cells detected in the biopsy. Low-level mosaicism (often defined as approximately 20 to 40 percent abnormal cells) is generally considered lower risk than high-level mosaicism (above 40 to 50 percent abnormal cells). The specific chromosome involved also matters. Mosaicism involving chromosomes known to be lethal in full trisomy is treated more cautiously than mosaicism involving chromosomes associated with more viable outcomes.
Can You Transfer a Mosaic Embryo?
Yes, mosaic embryo transfer is performed at fertility clinics when appropriate clinical conditions are met. The American Society for Reproductive Medicine (ASRM) and leading professional bodies have published guidance acknowledging that mosaic embryo transfer can be a reasonable option in specific circumstances, particularly when a patient has no euploid embryos available.
Success rates per transfer for mosaic embryos are lower than for euploid embryos but meaningfully higher than for fully aneuploid embryos. Published data suggests live birth rates for low-level mosaic embryo transfers of approximately 30 to 40 percent per transfer in some series, though this varies by mosaic level, chromosome, and patient factors.
When mosaic embryo transfer is considered, careful genetic counseling is an important part of the process. Patients should understand the available outcome data, including what is known about the small risk of the fetus carrying chromosomal findings, and make a decision that aligns with their values and circumstances.
"When a patient has a mosaic embryo and no euploid options, the conversation changes significantly. We are no longer comparing mosaic to euploid. We are comparing mosaic transfer to no transfer at all, or to another retrieval cycle. That is a completely different clinical and personal calculus, and we work through it with each patient individually."
— Dr. Diana LeBlanc, a Fertility Specialist at Hanabusa IVF
Mosaic Embryos in the Context of Failed IVF or Limited Embryos
For patients who have been through multiple IVF cycles, have produced few embryos, and have no euploid embryos available, mosaic embryo transfer may represent a meaningful pathway forward. Hanabusa IVF has experience managing complex cases including failed IVF, diminished ovarian reserve, and situations where patients are working with limited embryo cohorts. The decision about whether to pursue mosaic embryo transfer in these contexts is individualized and made with full transparency about the evidence.
Frequently Asked Questions
Is a mosaic embryo the same as an aneuploid embryo?
No. A fully aneuploid embryo has chromosomal abnormalities in all or nearly all cells and has a very low likelihood of resulting in a healthy pregnancy. A mosaic embryo has a mix of chromosomally normal and abnormal cells, and the outcome depends on the proportion of abnormal cells and which chromosomes are involved. Mosaic embryos have resulted in healthy births; aneuploid embryos very rarely do.
Can a mosaic embryo self-correct?
There is evidence from both animal studies and human case reports suggesting that embryos can undergo a process of chromosomal normalization, where abnormal cells are eliminated during early development. This may partially explain why some mosaic embryos result in chromosomally normal births. This process is not fully understood and cannot be predicted or guaranteed.
What are the risks of transferring a mosaic embryo?
The primary risks of mosaic embryo transfer are a lower implantation rate compared to euploid embryo transfer, and a small risk of the resulting fetus carrying chromosomal findings. Prenatal testing (amniocentesis or CVS) is typically recommended in mosaic transfer pregnancies to assess the chromosomal status of the fetus. The magnitude of risk depends on the level of mosaicism and the specific chromosome involved.
What should I do if all my embryos came back mosaic?
This is a situation that warrants a careful, individualized conversation with your physician. Options to discuss include mosaic embryo transfer (starting with the lowest-level mosaic or the embryo with the most favorable characteristics), pursuing another retrieval cycle to obtain additional embryos, considering donor egg options, or other approaches depending on your goals and circumstances. There is no single right answer.
How common is mosaicism in IVF embryos?
Estimates vary by laboratory and detection method, but mosaicism is detected in a meaningful proportion of biopsied blastocysts, often cited between 10 and 20 percent of those tested, though figures vary. The rate of true biological mosaicism in embryos may differ from the rate of mosaic findings on PGT-A reports, as some mosaic calls may reflect technical variability in the biopsy or testing process.
Making Informed Decisions About Mosaic Embryos
A mosaic embryo result is a starting point for a careful clinical conversation, not a definitive endpoint. At Hanabusa IVF, patients receive a clear explanation of what their PGT-A results mean, including the nuanced picture that mosaic findings present, and a recommendation grounded in their individual situation, embryo profile, and goals.
If you have received mosaic embryo results or have questions about how Hanabusa IVF approaches complex embryo selection decisions, a consultation is the right next step.
